Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00074
|
|||||
| Drug Name |
Allopurinol
|
|||||
| Synonyms |
4-HPP; A 8003; AL-100; Adenock; Ailural; Ailurial; Allo-Puren; Allohexal; Allohexal (TN); Allohexan; Alloprin; Allopur; Allopurin; Allopurinol(I); Allopurinolum; Allorin; Allosig (TN); Allozym; Allpargin; Allural; Aloprim; Alopurinol; Aloral; Alositol; Aluline; Anoprolin; Anzief; Apo-Allopurinol; Apulonga; Apurin; Apurol; Atisuril; B. W. 56-158; BW 56-158; BW 56158; BW-56-158; Bleminol; Bloxanth; Caplenal; Capurate; Cellidrin; Cosuric; Dabrosin; Dabroson; Dura Al; Embarin; Epidropal; Epuric; Foligan; Geapur; Gichtex; Gotax; Hamarin; Hexanuret; Jenapurinol; Ketanrift; Ketobun-A; Ledopur; Lopurin; Lysuron; Milurit; Milurite; Miniplanor; Monarch; Nektrohan; Novopurol; Pan Quimica; Progout; Progout (TN); Pureduct; Puricos (TN); Purinol; Quimica, Pan; Remid; Riball; Rimapurinol; Roucol; Sigapurol; Suspendol; Takanarumin; Tipuric; Urbol; Uribenz; Uricemil; Uridocid; Uriprim; Uripurinol; Uritas; Urobenyl; Urolit; Urosin; Urtias; Urtias 100; Xanthomax; Xanturat; Xanturic; Zygout; Zyloprim; Zyloprim (TN); Zyloric; Zyloric (TN)
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Hyperuricaemia [ICD11: 5C55.Y] | Approved | [1] | |||
| Therapeutic Class |
Antimetabolites
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C5H4N4O
|
|||||
| Canonical SMILES |
C1=NNC2=C1C(=O)NC=N2
|
|||||
| InChI |
InChI=1S/C5H4N4O/c10-5-3-1-8-9-4(3)6-2-7-5/h1-2H,(H2,6,7,8,9,10)
|
|||||
| InChIKey |
OFCNXPDARWKPPY-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 315-30-0
|
|||||
| Pharmaceutical Properties | Molecular Weight | 136.11 | Topological Polar Surface Area | 70.1 | ||
| Heavy Atom Count | 10 | Rotatable Bond Count | 0 | |||
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 3 | |||
| XLogP |
-0.7
|
|||||
| PubChem CID | ||||||
| PubChem SID |
10321496
, 10518263
, 11110781
, 11335860
, 11361099
, 11362800
, 11365362
, 11367924
, 11371398
, 11373689
, 11376086
, 11449337
, 11462071
, 11483792
, 11487914
, 11490105
, 11491950
, 11493840
, 15119988
, 15146664
, 17389550
, 17404665
, 22395219
, 24278141
, 26611594
, 26679243
, 26697339
, 26747845
, 26747846
, 29221274
, 3133506
, 3727085
, 404525
, 4266415
, 42880554
, 46508516
, 47440268
, 47589009
, 47737041
, 48259236
, 4826301
, 48415533
, 48422551
, 594917
, 6262863
, 68199
, 7348782
, 7836064
, 8139898
, 8149190
|
|||||
| ChEBI ID |
ChEBI:40279
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | OAT2 | Transporter Info | Organic anion transporter 2 | Substrate | [2] | |
| OAT3 | Transporter Info | Organic anion transporter 3 | Substrate | [3] | ||
| References | ||||||
| 1 | Allopurinol was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | Isolation, characterization and differential gene expression of multispecific organic anion transporter 2 in mice. Mol Pharmacol. 2002 Jul;62(1):7-14. | |||||
| 3 | Renal transport of organic compounds mediated by mouse organic anion transporter 3 (mOat3): further substrate specificity of mOat3. Drug Metab Dispos. 2004 May;32(5):479-83. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.